Presentation TCT 2022 Time to Move Beyond ISR – My Vision of the Future for Coronary DCB Technologies Presenter: Antonio Colombo September 17, 2022 REGISTER for free or LOG IN to view this content Coronary TCT 2022 DES/BRS/DCB Up Next Presentation TCT 2022 3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial Presenter: Bernardo Cortese September 17, 2022 More slides + Presentation TCT 2022 5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD Presenter: ShaoLiang Chen September 17, 2022 Presentation TCT 2022 DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB Presenter: Paul Underwood September 17, 2022 We Recommend Disclosures Nothing to disclose
Presentation TCT 2022 3-Year Outcome of paclitaxel DCB vs. DES for Native Vessel Disease Treatment: Final Follow Up of the Randomized PICCOLETO II Trial Presenter: Bernardo Cortese September 17, 2022
Presentation TCT 2022 5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD Presenter: ShaoLiang Chen September 17, 2022
Presentation TCT 2022 DCB for SVD: Primary Outcomes of a Multi-Center RCT with AGENT DCB Presenter: Paul Underwood September 17, 2022